首页 › 股票 › TRVI

TRVI — TREVI THERAPEUTICS INC

申报持仓市值$2.98B
持有基金数(最新)339
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)229
机构持仓市值$2.91B · 157.12M 股
新建/增持/减仓/清仓45 / 89 / 58 / 22 · 更新于 2026-11-14
前五大/前十大集中度33.7% / 48.7%
机构整体持仓变动 增持 +5.4% (+7.41M 股)
机构持仓市值变动 上升 +63.6%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 229 家机构在其最新 13F 申报中持有 TRVI(TREVI THERAPEUTICS INC),合计申报市值 $2.91B,对应 157.12M 股。按股数计算较上季度增持 5.4%(+7.41M 股),申报市值环比上升 63.6%。持仓集中度较高:前五大持有人占申报市值的 33.7%,前十大的集中度为 48.7%。

与上一季度相比,45 家新建仓位、89 家加仓、58 家减仓、22 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

TREVI THERAPEUTICS INC(TRVI)的主要机构持有人包括 NEA Management Company, LLC、Fidelity Management & Research (FMR)、Frazier Life Sciences Management, L.P.,按 13F 申报市值在本页 339 家持有人中排名居前。

TRVI 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

持有 TRVI 的传奇投资人

我们追踪的超级投资人在各自最新 13F 申报中持有 TRVI 的名单——每位投资人按其自身最近一个季度展示。

投资人 季度 股数 金额 组合权重 变化
维京全球 Q2 2026 1.54M $28.81M 0.08% 减持

这些投资人共同持有哪些股票?→  ·  嵌入此组件 →

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 154 81.33M $1.16B +8.6%
Q2 2026 229 157.12M $2.91B +5.4%
Q1 2026 206 142.59M $1.71B +3.3%
Q4 2025 191 135.40M $1.69B -5.9%
Q3 2025 174 138.95M $1.27B +19.0%
Q2 2025 159 115.77M $633.07M +24.4%
Q1 2025 145 93.49M $587.83M -2.1%
Q4 2024 112 82.25M $340.78M +12.5%

表内 8 个季度中,机构持股合计减少 1%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2025(+24.4%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 13.63M $195.18M 0.01% 增持
BlackRock Inc 12.29M $175.97M 0.00% 增持
VANGUARD CAPITAL MANAGEMENT LLC 6.11M $87.53M 0.00% 增持
Vivo Capital, LLC 历史持仓 4.23M $60.57M 6.88% 减持
Assenagon Asset Management S.A. 3.53M $50.51M 0.06% 增持
STATE STREET CORP 3.27M $46.86M 0.00% 增持
Marshall Wace 3.15M $45.12M 0.08% 增持
Geode Capital Management 2.96M $42.41M 0.00% 增持
EVENTIDE ASSET MANAGEMENT, LLC 2.55M $36.53M 0.51% 减持
Pictet Asset Management Holding SA 1.95M $27.94M 0.03% 减持
Affinity Asset Advisors, LLC 历史持仓 1.80M $25.78M 1.20% 持有
EMERALD ADVISERS, LLC 1.80M $25.70M 0.71% 持有
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 1.74M $24.96M 10.17% 持有
Siren, L.L.C. 历史持仓 1.52M $21.82M 0.52% 减持
Jones Hill Capital LP 历史持仓 1.45M $20.72M 3.52% 增持
Candriam S.C.A. 1.31M $18.80M 0.08% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 1.19M $17.01M 0.00% 增持
EMERALD MUTUAL FUND ADVISERS TRUST 1.18M $16.92M 0.69% 减持
NAN FUNG TRINITY (HK) Ltd 历史持仓 1.08M $15.51M 1.49% 减持
FLPUTNAM INVESTMENT MANAGEMENT CO 1.05M $14.99M 0.16% 增持
Franklin Resources 1.04M $14.60M 0.00% 增持
Qube Research & Technologies Ltd 880.40K $12.61M 0.03% 增持
VANGUARD FIDUCIARY TRUST CO 863.42K $12.36M 0.00% 增持
Nuveen, LLC 825.22K $11.82M 0.00% 增持
FEDERATED HERMES, INC. 773.74K $11.08M 0.02% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
NEA Management Company, LLC 历史持仓 13.22M $246.59M 15.53% 持有
Fidelity Management & Research (FMR) 12.56M $234.30M 0.01% 增持
BlackRock Inc 11.16M $208.04M 0.01% 增持
Frazier Life Sciences Management, L.P. 历史持仓 9.94M $185.37M 4.04% 持有
Wellington Management Group 5.68M $106.02M 0.02% 增持
WELLINGTON MANAGEMENT GROUP LLP 5.68M $106.02M 0.02% 增持
VANGUARD CAPITAL MANAGEMENT LLC 5.53M $103.15M 0.00% 增持
Vivo Capital, LLC 历史持仓 5.09M $95.02M 8.68% 持有
Woodline Partners LP 4.08M $76.12M 0.24% 增持
Vestal Point Capital, LP 历史持仓 3.10M $57.81M 1.35% 增持
MPM BioImpact LLC 历史持仓 3.07M $57.32M 3.50% 减持
FRONTIER CAPITAL MANAGEMENT CO LLC 3.07M $57.27M 0.53% 增持
GEODE CAPITAL MANAGEMENT, LLC 2.93M $54.62M 0.00% 新进
Geode Capital Management 2.93M $54.62M 0.00% 增持
Marshall Wace 2.67M $49.87M 0.09% 减持
EVENTIDE ASSET MANAGEMENT, LLC 2.66M $49.61M 0.66% 增持
Rubric Capital Management LP 2.50M $46.71M 0.43% 减持
Artia Global Partners LP 历史持仓 2.21M $41.23M 7.61% 增持
ACORN CAPITAL ADVISORS, LLC 历史持仓 2.14M $40.00M 10.92% 持有
First Light Asset Management, LLC 历史持仓 2.10M $39.11M 2.38% 新进
Pictet Asset Management Holding SA 2.01M $37.56M 0.04% 增持
Logos Global Management LP 历史持仓 1.88M $35.06M 1.51% 减持
Affinity Asset Advisors, LLC 历史持仓 1.80M $33.57M 1.61% 减持
EMERALD ADVISERS, LLC 1.80M $33.53M 0.79% 减持
Siren, L.L.C. 历史持仓 1.79M $33.33M 0.68% 持有

Q1 2026 — 25 家基金

基金股数金额组合权重变化
NEA Management Company, LLC 历史持仓 13.22M $157.74M 8.97% 持有
BlackRock Inc 10.24M $122.17M 0.00% 增持
Frazier Life Sciences Management, L.P. 历史持仓 9.94M $118.58M 3.05% 减持
Fidelity Management & Research (FMR) 8.04M $95.89M 0.01% 增持
Wellington Management Group 5.19M $61.91M 0.01% 增持
WELLINGTON MANAGEMENT GROUP LLP 5.19M $61.91M 0.01% 增持
Vivo Capital, LLC 历史持仓 5.09M $60.78M 5.05% 持有
VANGUARD CAPITAL MANAGEMENT LLC 4.98M $59.39M 0.00% 新进
Marshall Wace 3.97M $47.31M 0.07% 减持
Rubric Capital Management LP 3.71M $44.29M 0.47% 减持
MPM BioImpact LLC 历史持仓 3.30M $39.35M 3.04% 持有
Viking Global Investors 3.20M $38.16M 0.11% 持有
VIKING GLOBAL INVESTORS LP 3.20M $38.16M 0.11% 持有
ALLIANCEBERNSTEIN L.P. 2.85M $35.63M 0.01% 减持
Geode Capital Management 2.78M $33.15M 0.00% 增持
STATE STREET CORP 2.67M $31.80M 0.00% 增持
EVENTIDE ASSET MANAGEMENT, LLC 2.62M $31.28M 0.52% 持有
ORBIMED ADVISORS LLC 历史持仓 2.45M $29.28M 0.60% 减持
Logos Global Management LP 历史持仓 2.40M $28.63M 1.52% 增持
Vestal Point Capital, LP 历史持仓 2.17M $25.85M 0.72% 新进
ACORN CAPITAL ADVISORS, LLC 历史持仓 2.14M $25.59M 7.27% 持有
Artia Global Partners LP 历史持仓 2.01M $24.02M 6.06% 持有
Affinity Asset Advisors, LLC 历史持仓 2.00M $23.86M 1.28% 减持
FRONTIER CAPITAL MANAGEMENT CO LLC 1.99M $23.79M 0.24% 增持
EMERALD ADVISERS, LLC 1.84M $21.95M 0.69% 减持

Q4 2025 — 25 家基金

基金股数金额组合权重变化
NEA Management Company, LLC 历史持仓 13.22M $165.54M 8.44% 持有
Frazier Life Sciences Management, L.P. 历史持仓 10.26M $128.45M 3.45% 持有
BlackRock Inc 10.13M $126.78M 0.00% 增持
Fidelity Management & Research (FMR) 6.50M $81.38M 0.00% 增持
Vanguard Group 6.43M $80.56M 0.00% 增持
Vivo Capital, LLC 历史持仓 5.09M $63.79M 4.12% 持有
Marshall Wace 4.58M $57.35M 0.08% 减持
Rubric Capital Management LP 3.77M $47.16M 0.57% 减持
Wellington Management Group 3.40M $42.62M 0.01% 增持
WELLINGTON MANAGEMENT GROUP LLP 3.40M $42.62M 0.01% 增持
MPM BioImpact LLC 历史持仓 3.29M $41.15M 4.71% 减持
Viking Global Investors 3.20M $40.05M 0.11% 减持
VIKING GLOBAL INVESTORS LP 3.20M $40.05M 0.11% 减持
ORBIMED ADVISORS LLC 历史持仓 3.19M $39.95M 0.85% 减持
ALLIANCEBERNSTEIN L.P. 3.08M $38.60M 0.01% 减持
Octagon Capital Advisors LP 历史持仓 2.81M $35.24M 4.28% 持有
EVENTIDE ASSET MANAGEMENT, LLC 2.62M $32.83M 0.51% 增持
STATE STREET CORP 2.44M $30.49M 0.00% 增持
Geode Capital Management 2.41M $30.21M 0.00% 增持
Siren, L.L.C. 历史持仓 2.29M $28.63M 0.85% 减持
Affinity Asset Advisors, LLC 历史持仓 2.15M $26.92M 1.64% 减持
ACORN CAPITAL ADVISORS, LLC 历史持仓 2.14M $26.85M 9.10% 持有
Artia Global Partners LP 历史持仓 2.01M $25.21M 5.54% 增持
EMERALD ADVISERS, LLC 1.89M $23.69M 0.73% 新进
Logos Global Management LP 历史持仓 1.55M $19.41M 1.40% 减持

Q3 2025 — 25 家基金

基金股数金额组合权重变化
NEA Management Company, LLC 历史持仓 13.22M $120.98M 6.64% 持有
Frazier Life Sciences Management, L.P. 历史持仓 10.26M $93.87M 2.81% 持有
BlackRock Inc 9.90M $90.59M 0.00% 增持
Rubric Capital Management LP 8.53M $78.07M 0.89% 持有
Vanguard Group 5.83M $53.32M 0.00% 增持
VIKING GLOBAL INVESTORS LP 5.13M $46.93M 0.12% 增持
Viking Global Investors 5.13M $46.93M 0.12% 增持
Vivo Capital, LLC 历史持仓 5.09M $46.62M 3.75% 增持
Marshall Wace 4.84M $44.30M 0.07% 增持
Morgan Stanley 4.30M $39.36M 0.00% 增持
ALLIANCEBERNSTEIN L.P. 4.29M $39.28M 0.01% 持有
MPM BioImpact LLC 历史持仓 3.41M $31.17M 5.10% 持有
ORBIMED ADVISORS LLC 历史持仓 3.31M $30.27M 0.78% 持有
Fidelity Management & Research (FMR) 3.30M $30.19M 0.00% 增持
WELLINGTON MANAGEMENT GROUP LLP 3.25M $29.77M 0.01% 增持
Wellington Management Group 3.25M $29.77M 0.01% 增持
Octagon Capital Advisors LP 历史持仓 2.81M $25.76M 4.02% 减持
Affinity Asset Advisors, LLC 历史持仓 2.80M $25.62M 2.47% 增持
Siren, L.L.C. 历史持仓 2.54M $23.21M 0.91% 减持
Geode Capital Management 2.22M $20.33M 0.00% 增持
STATE STREET CORP 2.22M $20.31M 0.00% 增持
Logos Global Management LP 历史持仓 2.20M $20.13M 2.12% 增持
ACORN CAPITAL ADVISORS, LLC 历史持仓 2.14M $19.63M 9.96% 持有
Artia Global Partners LP 历史持仓 2.00M $18.30M 3.52% 增持
Bank of America Corp 1.84M $16.81M 0.00% 增持

Q2 2025 — 25 家基金

基金股数金额组合权重变化
NEA Management Company, LLC 历史持仓 13.22M $72.33M 5.44% 增持
Frazier Life Sciences Management, L.P. 历史持仓 10.26M $56.12M 2.24% 持有
Rubric Capital Management LP 8.53M $46.67M 0.71% 增持
BlackRock Inc 8.21M $44.88M 0.00% 增持
Vanguard Group 5.32M $29.08M 0.00% 增持
Vivo Capital, LLC 历史持仓 4.49M $24.55M 2.51% 增持
ALLIANCEBERNSTEIN L.P. 4.28M $23.42M 0.01% 增持
Woodline Partners LP 4.05M $22.13M 0.12% 增持
Siren, L.L.C. 历史持仓 3.94M $21.55M 1.11% 增持
Octagon Capital Advisors LP 历史持仓 3.67M $20.09M 4.41% 增持
MPM BioImpact LLC 历史持仓 3.41M $18.64M 3.23% 减持
ORBIMED ADVISORS LLC 历史持仓 3.31M $18.10M 0.47% 增持
Affinity Asset Advisors, LLC 历史持仓 2.53M $13.86M 2.14% 增持
Marshall Wace 2.48M $13.55M 0.02% 减持
Balyasny Asset Management 2.35M $12.88M 0.05% 增持
ACORN CAPITAL ADVISORS, LLC 历史持仓 2.14M $11.73M 7.67% 持有
STATE STREET CORP 1.83M $10.03M 0.00% 增持
Geode Capital Management 1.79M $9.78M 0.00% 增持
Point72 Asset Management 1.73M $9.46M 0.05% 减持
VIKING GLOBAL INVESTORS LP 1.54M $8.44M 0.02% 减持
Viking Global Investors 1.54M $8.44M 0.02% 减持
EVENTIDE ASSET MANAGEMENT, LLC 1.38M $7.56M 0.13% 新进
Artia Global Partners LP 历史持仓 1.31M $7.18M 2.84% 新进
Pivotal bioVenture Partners Investment Advisor LLC 历史持仓 1.15M $6.27M 3.89% 新进
Bank of America Corp 1.10M $6.00M 0.00% 增持

查看全部 339 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Fidelity Management & Research (FMR) 13.63M 12.56M 8.04M 6.50M 3.30M 368.53K 6.00K 4.36K 3.69K 3.60K 3.54K 3.51K 1.58K 886 — — 1.56M 83.22K — —
BlackRock Inc 12.29M 11.16M 10.24M 10.13M 9.90M 8.21M 5.31M 3.93M 3.22M — — — — — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 6.11M 5.53M 4.98M — — — — — — — — — — — — — — — — —
Vivo Capital, LLC 4.23M 5.09M 5.09M 5.09M 5.09M 4.49M 3.49M 3.49M 1.61M — — — — — — — — — — —
Assenagon Asset Management S.A. 3.53M 1.53M — — — — — — — — — — — — — — — — — —
STATE STREET CORP 3.27M — 2.67M 2.44M 2.22M 1.83M 1.42M 1.17M 952.91K 899.86K 798.25K 741.19K 708.59K — — — — — — —
Marshall Wace 3.15M 2.67M 3.97M 4.58M 4.84M 2.48M 2.55M 42.92K 81.12K — — — — — — — 128.32K — 23.40K —
Geode Capital Management 2.96M 2.93M 2.78M 2.41M 2.22M 1.79M 1.61M 1.30M 1.26M 1.15M 897.97K 849.88K 787.64K 778.82K 248.29K 211.55K 200.22K 195.15K 72.74K 49.08K
EVENTIDE ASSET MANAGEMENT, LLC 2.55M 2.66M 2.62M 2.62M 1.38M 1.38M — — — — — — — — — — — — — —
Pictet Asset Management Holding SA 1.95M 2.01M 1.71M 1.53M 11.26K — — — — — — — — — — — — — — —
Affinity Asset Advisors, LLC 1.80M 1.80M 2.00M 2.15M 2.80M 2.53M 1.25M — — — — — — — — — — — — —
EMERALD ADVISERS, LLC 1.80M 1.80M 1.84M 1.89M — — — — — — — — — — — — — — — —
Pivotal bioVenture Partners Investment Advisor LLC 1.74M 1.74M 1.55M 1.26M 1.26M 1.15M — — — — — — — — — — — — — —
Siren, L.L.C. 1.52M 1.79M 1.79M 2.29M 2.54M 3.94M 2.86M 2.91M — — — — — — — — — — — —
Jones Hill Capital LP 1.45M 1.34M 370.18K — — — — — — — — — — — — — — — — —
Candriam S.C.A. 1.31M 966.22K 773.62K — — — — — — — — — — — — — — — — —
VANGUARD PORTFOLIO MANAGEMENT LLC 1.19M 1.18M 968.59K — — — — — — — — — — — — — — — — —
EMERALD MUTUAL FUND ADVISERS TRUST 1.18M 1.21M 1.26M 1.27M — — — — — — — — — — — — — — — —
NAN FUNG TRINITY (HK) Ltd 1.08M 1.21M 1.14M 917.45K 89.58K — — — — — — — — — — — — — — —
FLPUTNAM INVESTMENT MANAGEMENT CO 1.05M 1.04M 1.06M 1.05M 1.05M 86.95K — — — — — — — — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold TRVI?

As of 2026-Q2, 229 institutional funds reported holding TRVI (TREVI THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $2.91B.

How many shares of TRVI do institutions own?

13F filers reported 157.12M shares of TRVI, worth $2.91B in aggregate at the end of 2026-Q2.

Is institutional ownership of TRVI rising or falling?

Share counts moved +5.4% versus the prior quarter — accumulation.

Who are the top institutional holders of TRVI?

The largest 13F holders are NEA Management Company, LLC, Fidelity Management & Research (FMR), Frazier Life Sciences Management, L.P., BlackRock Inc, Wellington Management Group; the top 25 are ranked at the top of this page.

Who are the major shareholders of TREVI THERAPEUTICS INC?

The major shareholders of TREVI THERAPEUTICS INC (TRVI) by reported 13F value are NEA Management Company, LLC, Fidelity Management & Research (FMR), Frazier Life Sciences Management, L.P., BlackRock Inc, Wellington Management Group, among 339 institutional holders.

Which legendary investors own TRVI?

1 of the legendary investors tracked on HoldingsHub report TRVI (TREVI THERAPEUTICS INC) in their latest 13F filings, led by Viking Global Investors. Each is shown at that manager's own most recent quarter.

Do superinvestors agree on TRVI?

1 tracked superinvestors hold TRVI simultaneously — see the consensus page for the stocks they own together.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 TRVI」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/TRVI/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →